輪證日報|錦欣生殖逆勢上漲，認購證漲50%
今日市場短評
港股午後受科技股拖累，恆指跳水一度失守兩萬四，恆生科技指數尾盤跌超3%。截至收盤，恆指收跌157點或0.65%，恆生科技指數收跌2.78%。遊戲股、餐飲股、教育股跌拖累大市，菸草股、物流股、電信股逆市上揚。個股方面，正榮地產收跌1.79%，心動公司收跌11.79%，嗶哩嗶哩收跌9.59%，諾輝健康收漲13.11%，錦欣生殖收漲8.77%，京東物流收漲8.54%。
窩輪（認股證）焦點
錦欣生殖（01951）
錦欣認購證（17820）到期日：2022年9月
槓桿：3.64倍
錦欣生殖午後漲幅擴大逾12% 北京16項輔助生殖技術項目納入醫保報銷
消息面上，北京市醫保局近日會同市衛生健康委、市人力社保局印發《關於規範調整部分醫療服務價格項目的通知》。其中，爲實施積極生育支持措施，通過組織專家論證，在費用可控、確保醫保基金可承受的基礎上，將門診治療中常見的宮腔內人工授精術、胚胎移植術、精子優選處理等16項涉及人羣廣、診療必需、技術成熟、安全可靠的輔助生殖技術項目納入醫保甲類報銷範圍。
牛熊證焦點
中國移動（00189）
中移牛證（51591）到期日：2022年12月
回收價：53.55槓桿：17
中國移動升逾2% 中國移動咪咕將與王濛開啓全新合作
公司公佈，於2022年02月18日回購363萬股，每股回購價介乎54.20港元至55.00港元，涉資1.99億元。本年內至今爲止(自普通決議案通過以來) 累計購回證券數目爲1516.3萬股，佔於普通決議案通過時已發行股份數目的0.074%。
此外，爲了迴應和滿足大衆呼聲，黃健翔受中國移動咪咕委託，正式宣佈王濛將真正“焊死”在咪咕解說席上，並在後續開啓全新週期的深度合作，“焊死”在咪咕各個業務板塊和領域中。
後續，廣大觀衆可以在咪咕體育賽事解說、自制綜藝、視頻彩鈴、健身課程等看見王濛。此外，咪咕還將與王濛的體育MCN機構開啓全方位的合作，挖掘和賦能更多體育運動員價值。同時，由王濛與一衆明星嘉賓加盟的運動類真人綜藝節目《運動者聯濛》，也正於每天中午12點在咪咕視頻全網播出。
衍生品資金流入/流出
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
